INTRODUCTION
============

It is now clear that misregulation of stem cell fate and division is an important component of neoplasia ([@b59-0040067]). Some tumors (at least in the case of blood, breast, skin, brain and colon cancer) might originate from malignant transformation of stem cells ([@b67-0040067]; [@b96-0040067]; [@b98-0040067]; [@b144-0040067]). Moreover, because cancer development fundamentally involves the loss of morphogenetic order ([@b99-0040067]; [@b105-0040067]; [@b134-0040067]), it is not surprising that the same signaling pathways (TGFβ, Wnt, Notch, etc.) seem to regulate self-renewal in embryonic patterning, stem cells and cancer cells ([@b8-0040067]; [@b22-0040067]; [@b72-0040067]; [@b144-0040067]; [@b187-0040067]). Developmental systems serve as convenient models for studies of cancer because they allow access to a number of stem cell populations throughout embryogenesis and benefit from well-documented regulatory networks that underlie differentiation and patterning. Perturbations that induce neoplasia-like phenotypes during embryogenesis allow great insight into the signals leading to the creation of cancer stem cells and many such links have already been established ([@b44-0040067]; [@b43-0040067]; [@b167-0040067]; [@b181-0040067]).

Thus, stem cells are at the center of the regeneration-development-cancer triad ([@b185-0040067]). The construction of replacement tissues or organs through stem cell therapy or in vitro bioengineering is a fundamental hope of regenerative medicine. Although much effort is directed towards coaxing stem cells to differentiate into specific cell types, the next frontier will involve learning to harness individual cellular dynamics to achieve complex multicellular morphogenesis. Building replacement organs or whole appendages to address birth defects, tumors, degenerative disease, injury and infectious morbidity will require not merely the presence of the right cell types, but also their integration into three-dimensional highly complex structures of appropriate physiological and mechanical function ([@b75-0040067]). This in turn will require a detailed understanding of the role of the cellular environment of the host in regulating the behavior of stem and cancer cells alike ([@b74-0040067]; [@b159-0040067]).

The neural crest, a crucial population of embryonic stem cells that contributes to many structures during development ([@b150-0040067]), differentiates into a variety of cell types, including smooth muscle cells, peripheral neurons and glia, and craniofacial cartilage and bone, as well as endocrine and pigment cells. The biology of neural crest regulation is also of significant biomedical relevance because neurocristopathies form an important class of birth defects ([@b18-0040067]; [@b24-0040067]; [@b76-0040067]). These cells are an ideal context in which to explore the common mechanisms regulating stem cells and neoplastic processes ([@b38-0040067]; [@b53-0040067]; [@b176-0040067]), especially with respect to pigment cell derivatives ([@b37-0040067]; [@b185-0040067]). These cells not only reveal dynamics of migration control ([@b95-0040067]; [@b115-0040067]), but are also an important subject for understanding melanoma ([@b62-0040067]; [@b62-0040067]) and in learning to control biological assembly in vitro for tissue engineering ([@b117-0040067]).

One of the most interesting areas of inquiry involves epigenetic controls of tumor progression and stem cell function ([@b15-0040067]; [@b28-0040067]; [@b45-0040067]; [@b81-0040067]; [@b136-0040067]; [@b147-0040067]; [@b184-0040067]). It is becoming clear that the microenvironment is a key player that mediates epigenetic signaling mechanisms ([@b21-0040067]; [@b66-0040067]; [@b159-0040067]; [@b178-0040067]). Importantly, it is now known that cell behaviors are controlled not only by secreted chemical factors, traction forces and extracellular matrix, but also by bioelectrical events. Ionic controls of differentiation, proliferation and migration have been investigated for decades ([@b26-0040067]; [@b80-0040067]; [@b113-0040067]; [@b129-0040067]; [@b145-0040067]), with solid functional data demonstrating instructive roles in growth control, limb regeneration and anterior-posterior polarity. More recently, the investigation of bioelectric signals has been accelerated by the availability of high-resolution molecular-genetic tools allowing the functional dissection of the endogenous roles of ion flows, voltage gradients and electric fields, and their linkage to canonical genetic and biochemical networks ([@b3-0040067]; [@b4-0040067]; [@b6-0040067]; [@b143-0040067]; [@b158-0040067]; [@b194-0040067]). Indeed, voltage- and current-mediated signals are now known to carry morphogenetic information, including signals regulating embryonic left-right patterning, wound healing and neuromuscular appendage regeneration ([@b103-0040067]; [@b104-0040067]; [@b118-0040067]; [@b119-0040067]), as well as controlling cell-level behaviors such as cell migration and proliferation ([@b23-0040067]; [@b141-0040067]; [@b142-0040067]; [@b166-0040067]).

It is known that transmembrane voltage is a powerful determinant of proliferative potential in somatic cells ([@b20-0040067]; [@b23-0040067]; [@b35-0040067]; [@b130-0040067]); moreover, genomic analyses and microarray screens have now revealed a number of ion channels to be key players in neoplasm ([@b10-0040067]; [@b11-0040067]; [@b52-0040067]). Recent studies have shown that stem cells exhibit unique electrophysiological profiles ([@b19-0040067]; [@b29-0040067]; [@b57-0040067]; [@b68-0040067]; [@b180-0040067]). Likewise, ionic currents and channels have been found to play important roles during myoblast, cardiomyocyte, mesenchymal and neural stem cell differentiation ([@b19-0040067]; [@b33-0040067]; [@b87-0040067]; [@b164-0040067]; [@b165-0040067]; [@b180-0040067]).

However, much of this work was done in vitro, which does not reveal the complex interactions that are required to integrate stem cell function into complex morphogenetic programs. Thus, the ability of endogenous electrical signals to act as a functional biophysical control mechanism in stem cell biology in vivo is very poorly understood. Recently, in the *Xenopus laevis* embryonic system, we showed that misexpression of a regulatory subunit of the KCNQ1 potassium channel was able to induce hyperproliferation of melanocytes and a hyperpigmented phenotype that did not involve increases of pigment content per cell or the conversion of other cell types into melanocytes ([@b121-0040067]). This work revealed an entirely novel control of melanocyte behavior and led to several new questions. First, because misexpression of channel mRNA must be performed at cleavage stages, the timing of the melanocyte-instructive event could not be functionally characterized. Second, for the purposes of using bioelectrical controls of cell behavior for regenerative medicine or oncology, it is essential to develop techniques that do not rely on the introduction of transgenes because of the numerous problems attendant with gene therapy in human patients ([@b137-0040067]; [@b171-0040067]). Third, it is not known which cells, in what anatomical region, must be depolarized for the melanocytes to acquire the metastatic phenotype. Finally, it is not known what cells in the embryo endogenously have the ability to signal to neural crest descendants when their membrane voltage potential (*V*~mem~) is modulated, nor whether the KCNE1-induced signaling could be exerted by proteins other than the KCNE1-KCNQ1 potassium channel complex.

Therefore, we developed a strategy capitalizing on the ability to control the native glycine receptor chloride channel (GlyCl), and thereby control the steady-state transmembrane potential of GlyCl-expressing embryonic cells. Molecular-genetic or pharmacological depolarization of GlyCl-expressing cells confers a neoplasia-like phenotype on melanocytes: they overproliferate, become arborized and inappropriately colonize numerous tissues in a metalloprotease-dependent fashion. A similar effect is observed in cultured human melanocytes. The effect is specific to *V*~mem~ (not dependent on GlyCl per se or even chloride flux), is not cell-autonomous and is mediated by voltage control of serotonin \[5-hydroxytryptamine (5-HT)\] transport. These data (1) identify GlyCl as a unique marker of cells that can control melanocyte behavior non-cell-autonomously, (2) reveal a novel mechanism by which bioelectrical properties of the microenvironment mediate the stem-cell--cancer-cell transition and (3) suggest a new class of strategies for manipulating embryonic stem cell behavior without the need for gene therapy.

RESULTS
=======

Exposure to chloride channel opener specifically induces hyperpigmentation
--------------------------------------------------------------------------

To investigate the role of bioelectric signals during embryogenesis and develop a strategy that could ultimately be used in biomedical settings, we first developed a method for modulating transmembrane potential in select groups of cells in vivo. Chloride channels are a convenient target because, once opened, Cl^−^ ions can be made to exit or enter the cell when the extracellular level of chloride (\[Cl^−^\]~ex~) in the medium is artificially varied ([@b100-0040067]): levels of \[Cl^−^\]~ex~ that are lower than that of intracellular chloride will lead to the exit of negative ions and thus depolarize the cells. Conversely, a high chloride medium will cause hyperpolarization by allowing negative ions to enter cells down their concentration gradient. To open chloride channels, we utilized ivermectin -- a drug commonly used as an antiparasitic agent owing to the paralyzing effect it has on muscle cells in nematodes ([@b131-0040067]). This compound is well-characterized, specifically opening GlyCl, and is already approved for use in human patients and veterinary medicine ([@b154-0040067]).

Untreated wild-type *Xenopus* embryos develop characteristic pigment patterns after a fraction of neural crest derivatives become determined as melanocytes during late neurulation and somite stages ([@b34-0040067]; [@b93-0040067]) and begin to produce melanin during tailbud stages. The majority of melanocytes occupy a medial position in the head and trunk of young tadpoles ([Fig. 1A,A′](#f1-0040067){ref-type="fig"}). *Xenopus* developing in 0.1× Modified Marc's Ringers (MMR) medium, \[Cl^−^\]=10 mM {lower than internal Cl^−^ concentration (\[Cl^−^\]~int~), which is 40--60 mM}, were exposed to 10 μM ivermectin, which, under these conditions, is a depolarizing agent affecting cells that express GlyCl (supplementary material Fig. S1). Treatment throughout development from early neurulation paralyzed older tadpoles, as expected from the depolarization effect. Strikingly, it also resulted in extensive hyperpigmentation. Melanocytes in treated individuals often migrated to regions normally devoid of pigment cells, such as the lateral eye field ([Fig. 1B](#f1-0040067){ref-type="fig"}, red arrows) and the dorsal and ventral fins ([Fig. 1B″,B″′](#f1-0040067){ref-type="fig"}), and filled the core of the tail ([Fig. 1B′](#f1-0040067){ref-type="fig"}). This phenotype occurred in 98% of treated larvae ([Fig. 1C](#f1-0040067){ref-type="fig"}; supplementary material Movies 1 and 2); importantly, however, development was otherwise normal. Embryos showed no differences in growth rate or morphogenesis compared with wild type, and had a normal dorsoanterior index in addition to proper patterning of the body axis and organs. Other neural-crest-derived organs such as the branchial arches were apparently normal, arguing against significant deviation of neural crest streams from other targets. We conclude that pharmacological opening of chloride channels in embryos specifically results in hyperpigmentation.

Ivermectin-induced hyperpigmentation involves inappropriate migration, ectopic colonization and cell shape change
-----------------------------------------------------------------------------------------------------------------

To determine whether the hyperpigmentation was due to migration of melanocytes to inappropriate locations, and whether this process, like metastasis, depends on metalloproteases (MMPs), we treated embryos with a combination of ivermectin and the well-characterized MMP inhibitor NSC-84093, which blocks melanocyte movement in frog embryos ([@b173-0040067]; [@b174-0040067]). The resulting embryos ([Fig. 1D,D′](#f1-0040067){ref-type="fig"}) exhibited hyperpigmentation in regions normally inhabited by melanocytes (above the neural tube) but revealed an absence of ectopic melanocytes in periocular locations ([Fig. 1D](#f1-0040067){ref-type="fig"}, yellow arrows). We conclude that ectopic melanocytes colonize inappropriate embryonic regions via MMP-dependent cell migration processes. Interestingly, the melanocytes did not colonize the area above the pineal gland ([Fig. 1B,D](#f1-0040067){ref-type="fig"}, blue arrow), suggesting that they might still be responsive to specific restrictive signals that can demarcate quite sharp boundaries between permitted and restricted regions. We attempted to recapitulate this effect and restrict the metastatic melanocytes from other regions by inducing foci of high melatonin, but this was unsuccessful, suggesting that the repulsive effect of the pineal is not due exclusively to melatonin (data not shown).

One important component of the phenotype was a notable increase in cell arborization ([Fig. 1A′](#f1-0040067){ref-type="fig"} vs [Fig. 1B′](#f1-0040067){ref-type="fig"} and [Fig. 2](#f2-0040067){ref-type="fig"}; see supplementary material Fig. S1F and its legend for evidence that pigment pattern is a reliable indicator of overall shape in melanocytes). The arborization remained despite MMP inhibition ([Fig. 1D,D′](#f1-0040067){ref-type="fig"}), suggesting that the hyperpigmentation is due not only to melanocytes being present in ectopic locations, but also to a separate process involving shape change. This was clearly apparent in sections of hyperpigmented tadpoles, which revealed extensive tissue occupation by ectopic melanocytes. In sections, wild-type animals typically have sparse pigmentation along the lateral epidermis and around the neural tube ([Fig. 2A,B](#f2-0040067){ref-type="fig"}), exhibiting only a small number of round melanocytes. Ivermectin-exposed hyperpigmented embryos instead possess dramatic melanocyte coverage around the majority of the epidermis and the neural tube ([Fig. 2C,D](#f2-0040067){ref-type="fig"}), which includes the change of cells from a rounded morphology to a spread-out highly arborized shape with long processes.

![**Ivermectin exposure induces hyperpigmentation.** (A) Control embryos display a medially concentrated pigment pattern with the lateral eye field being largely devoid of melanocytes. (A′) The tail normally has a distributed population of round melanocytes over its core. (B) Embryos exposed to the chloride channel activator ivermectin while developing in the normal 10 mM Cl^−^ medium acquire a hyperpigmented phenotype by stage 42 despite otherwise normal development; ectopic melanocytes are present (periocular region indicated by red arrows; compare to similar region in panel A), and (B′) are more numerous and spread out in the tail. Ectopic melanocytes are also found in the dorsal and ventral fins (compare B‴ to control tails in B″). White arrows indicate fin region normally devoid of melanocytes; red arrowheads indicate ectopic melanocytes. (C) The ivermectin-induced phenotype was highly penetrant, with 98% of treated embryos developing hyperpigmentation (error bars indicate one standard deviation, *n*=189 for controls, *n*=174 for ivermectin-exposed). (D) When migration was blocked by the MMP inhibitor NSC-84093 in ivermectin-exposed embryos, colonization of ectopic locations by melanocytes was prevented (yellow arrows) but the abnormal arborization remained. The effect was also observed in the tail (D′), with the ventral area remaining uncolonized. Blue arrow indicates the location of an area that remains free of ectopic melanocytes, even in heavily hyperpigmented tadpoles, possibly overlying the pineal gland.](DMM005561F1){#f1-0040067}

![**Ivermectin induces invasiveness in melanocytes.** Compared to control embryos (A,B), those exposed to ivermectin (IVM) throughout development (C,D) show significantly more melanocyte coverage of the neural tube (NT) and epidermis (red arrows). Ivermectin-treated embryos removed from ivermectin at stage 43 (E,F) still show increased pigment cell number compared with controls, but the cells lose their arborized phenotypes. In addition, ivermectin induces melanocyte colonization of the gut (G,H) and the interior of the neural tube (I), and invasiveness of projections throughout the mesoderm between the epidermis and neural tube (J), indicated by red arrows. Schematics of *Xenopus laevis* embryo stages were retrieved from Xenbase, University of Calgary, Alberta T2N 1N4, Canada; <http://www.xenbase.org/>; August 2010.](DMM005561F2){#f2-0040067}

We next investigated whether the effect was reversible. Embryos removed from ivermectin-containing medium at stage 43 (after melanocytes had migrated) and analyzed 2 days later also showed an increase in melanocyte number compared with controls but did not maintain the abnormal arborization ([Fig. 2E--H](#f2-0040067){ref-type="fig"}). We conclude that the arborized phenotype is reversible; however, the ectopic melanocytes remain once they colonize the region.

The migratory properties of these ectopic melanocytes were extensive. They colonized not only the lumen of the neural tube, but also penetrated the dense neural tissues ([Fig. 2I](#f2-0040067){ref-type="fig"}). They also sent very long projections from the edges of the somite into the neural tube ([Fig. 2J](#f2-0040067){ref-type="fig"}). We conclude that depolarization via chloride channel opener induces aberrant targeting and a high degree of migration while radically changing the normal morphology of melanocytes -- a phenotype that is reminiscent of metastasis.

Early ivermectin exposure results in an increased number of melanocytes
-----------------------------------------------------------------------

We next investigated whether the hyperpigmentation effect involves increased numbers of melanocytes, in addition to ectopic migration and shape change. Exposed embryos were anesthetized and photographed; we then counted the number of melanocytes within a standard region defined by the eyes ([Fig. 3A,B](#f3-0040067){ref-type="fig"}), and compared each treatment to age-matched control siblings. Embryos exposed to 10 μM ivermectin from stages 12--24 (gastrulation through to the completion of neurulation), washed three times and cultured in plain 0.1× MMR, show a 1.5-fold increase in melanocyte number compared with controls ([Fig. 3C](#f3-0040067){ref-type="fig"}; ANOVA Tukey post-hoc, *P*\<0.05). These results were not confined to the eye field: melanocyte counts in the tip of the tail also showed a significant 1.5-fold increase when exposed to ivermectin throughout development (Student's *t*-test, *t*=6.069, *P*≤0.001). Importantly, we detected no increase in total melanin content above that explained by the increase in cell number (absorption at 414 nm: control=0.0534, ivermectin-treated=0.0656, *n*=5 embryos per treatment, repeated five times, 1.2-fold difference); because the increase in melanocyte number (1.5-fold) is bigger than the increase in melanin content, each melanocyte is actually less pigmented in ivermectin-exposed tadpoles, ruling out higher pigment synthesis as a contributing factor to the hyperpigmented appearance.

Excess melanocytes can arise from increases in proliferation, change of cell fate of additional cells into melanocytes, or perhaps even failure of apoptosis. Quantification of cells positive for caspase-3 staining ([@b175-0040067]) in sections showed no significant difference between control and ivermectin-treated embryos (11.3 vs 10.2 apoptotic cells in the notochord of control vs ivermectin-treated embryos, respectively, *n*=11, *P*=0.6), ruling out prevention of programmed cell death as a likely reason that higher numbers of melanocytes are observed. We next investigated whether additional cells were being recruited towards a melanocyte fate by expression analysis of *Trp2* (also known as *Dct*), a definitive marker of mature melanocytes ([@b91-0040067]). Embryos treated with ivermectin from stage 11 that were examined for expression of *Trp2* at stage 28 (prior to the migration of pre-melanocytes away from the neural crest) showed no ectopic signal ([Fig. 3D,E](#f3-0040067){ref-type="fig"}), indicating that regions that later exhibit abnormal numbers of melanocytes do not do so because of any recruitment of additional cells towards this lineage. Counting melanocytes in sections, to rule out excess recruitment towards melanocyte lineage within the crest itself (which would be difficult to detect in whole-mount) revealed that control embryos have the same number of melanocytes in the dorsal neural tube as do ivermectin-treated embryos (*n*=10 embryos, *P*=0.33) ([Fig. 3F,G](#f3-0040067){ref-type="fig"}). Given the lack of evidence for recruitment of additional cells into melanocytes at the time when a subset of neural crest cells are assigned a pigment cell fate, we suggest that ivermectin treatment during early stages results in excess melanocytes in later embryos via increased proliferation of mature melanocytes. To confirm the effect on proliferation of melanocytes, we characterized cell proliferation using an antibody to phosphorylated histone 3B (H3B-*P*) -- a standard marker of cells in the G2-M transition of the cell cycle, useful for identifying mitotic cells in *Xenopus* ([@b148-0040067]; [@b149-0040067]). Embryos were stained for the melanocyte marker Trp2 using in situ hybridization to identify melanocytes and then sectioned and processed for immunohistochemistry with anti-H3B-*P* antibody. Overlays of the bright-field ([Fig. 3H,H′](#f3-0040067){ref-type="fig"}) and fluorescent ([Fig. 3I,I′](#f3-0040067){ref-type="fig"}) signals allowed counting of all melanocytes that were actively dividing (cells positive for both markers). The data are summarized in [Table 1](#t1-0040067){ref-type="table"}, and show that, although embryos exposed at stage 16 and analyzed at stage 28 have the same number of mitotic melanocytes as controls, ivermectin-exposed embryos analyzed at stage 35 have a 2.8-fold increase in the number of melanocytes in mitosis over controls. These data confirm the induction of mitosis in mature melanocytes by ivermectin exposure.

![**Early ivermectin exposure induces an increase in pigment cell proliferation.** Embryos exposed to ivermectin from stages 10--24 (early) or 28--46 (late) both show darkening due to expansion of melanocytes. To determine whether there was also a corresponding increase in melanocyte number, photographs were taken of controls (A) and ivermectin-exposed (B) embryos after tricaine anesthetization, which contracts the pigment cells. The number of melanocytes in the eye field (red boxes) were then counted. Early exposed embryos showed a 1.5-fold increase in melanocyte number relative to controls (C), whereas no detectable difference was observed between late exposed embryos and controls. Error bars indicate one standard deviation; *n*=24 embryos for each treatment. Control embryos processed in in situ hybridization for the melanocyte marker *Trp2* at stage 28 show the normal pattern of expression prior to the migration of melanocytes away from the dorsal neural tube (D). Ivermectin-treated embryos show precisely the same pattern (E) and exhibit no evidence of ectopic locations being converted into a melanocyte fate by the ivermectin treatment. Sectioning reveals that control (F) and ivermectin-treated (G) embryos have the same number of melanocytes at the neural tube, also ruling out local shifts of neural crest cells into the melanocyte lineage as the explanation for later hyperpigmentation. Red arrows indicate positive signal (melanocytes indicated by *Trp2* expression), whereas white arrows indicate lack of signal. (H-I′) To directly analyze proliferation in melanocytes, embryos were stained for the melanocyte marker Trp2 using in situ hybridization to identify pigment cells, and were then sectioned and processed for immunohistochemistry with anti-H3B-*P* antibody. (H) Trp2 section in control embryos; (H′) corresponding signal of H3B-*P* stain in the same section. (I) Trp2 section in ivermectin-exposed embryos; (I′) corresponding signal of H3B-*P* stain in the same section. Overlays of the bright-field and fluorescent signals from the same section allowed quantification of the number of melanocytes that were in mitosis. At stage 28, there was no difference (*P*\>0.2, *n*=6) between controls and ivermectin-treated embryos. By stage 35, there was a significant increase in the number of mitotic melanocytes in the ivermectin-treated embryos (*P*\<0.009, *n*=6).](DMM005561F3){#f3-0040067}

Interestingly, embryos whose ivermectin exposure did not begin until stage 28 (lasting tailbud through tadpole), after a subset of the neural crest has been determined into melanocytes ([@b92-0040067]), did not show a significant increase in melanocytes at stage 46 compared with control animals ([Fig. 3C](#f3-0040067){ref-type="fig"}). These results demonstrate that, whereas early-exposed neural crest cells respond to ivermectin by increasing proliferation of committed melanocytes, exposure to ivermectin late in development induces a shape change and aberrant migration in pigment cells but not an increase in proliferation of the melanocytes.

![**Expression of GlyCl-**α **mRNA and protein.** In situ hybridization was performed on *Xenopus* embryos with an antisense probe to GlyCl-α. Expression (red arrows) was first detected during neurulation in the developing neural plate (A; panel B shows a thick section in profile because expression was too weak to be clearly visible in thin sections). Expression became restricted during somite stages (C) with foci of staining observed in the ventral marginal zone of the neural tube (NT) (E). Sections also revealed punctate signal in the lateral mesoderm (F, red arrows), which was not observed in the no-primary control (D), and an absence of signal in the dorsal neural tube, where many melanocytes are located (F, white arrows). In panels A--F, red arrows indicate expression of *GlyCl* mRNA, whereas white arrows indicate lack of expression in the dorsal neural tube from which melanocytes originate. Immunohistochemistry (with an antibody to GlyCl; green signal and red arrowheads) and in situ hybridization (with a probe to the melanocyte marker *Trp2*, blue arrows) on the same section of stage-31 embryos (G) revealed that the cells expressing GlyCl are at some distance from melanocytes (melanocytes do not themselves express the ivermectin target protein). (H) As an additional test of long-range signaling, embryos were injected with KCNE1+β-gal mRNA at the 16-cell stage in blastomeres, which resulted in depolarizing potassium channel subunit expression in posterior ventral tissues (blue arrow indicates β-galactosidase lineage label). Red arrowheads in panels H,I indicate hyperpigmentation (aberrant melanocytes) in the region; white arrowhead in H indicates absence of β-gal signal from anterior regions. They were continuously treated with NSC-84093 to prevent melanocyte migration from distant regions of the embryo. Sectioning (I,I′) revealed that hyperpigmentation occurred in the head and on the contralateral side, demonstrating that the metastasis-inducing signal is able to cross considerable distance along the anterior-posterior axis (from somites over the gut into the space anterior to the eyes) and across the embryonic midline (red arrowhead in I′) even when melanocytes local to the KCNE1 depolarization are prevented from moving. Insets in A and G taken from Nieuwkoop and Faber ([@b126-0040067]); schematic inset in G shows plane of sections for panels D--G. (J) A small section of neural plate from a ubiquitous GFP-transgenic donor treated with ivermectin (green arrowheads) was transplanted into an untreated host at stage 18, resulting in a hyperpigmentation phenotype (red arrowheads). (J′) Similar transplant performed from an ivermectin-treated donor results in GFP-labeled melanocytes (lighter in color owing to overlap of fluorescence and black pigment; green arrowheads) shows that these melanocytes take up ectopic positions next to native melanocytes (white arrowheads) and acquire the same highly arborized shape.](DMM005561F4){#f4-0040067}

The hyperpigmentation induced by ivermectin is mediated by GlyCl
----------------------------------------------------------------

Having characterized the basic properties of the phenotype, we then investigated the detailed mechanism of action. First, to confirm that the hyperpigmentation effect in *Xenopus* embryos is indeed mediated by GlyCl, and not some off-target property of ivermectin, we exposed embryos to the endogenous ligand of GlyCl, glycine. This control has an additional advantage in that glycine binds to GlyCl at a site different than that used by ivermectin ([@b154-0040067]). Treatment with 0.13 mM glycine induced the same hyperpigmented phenotype as ivermectin (supplementary material Fig. S2), indicating that the modulation of pigment cell number, shape and location by ivermectin is indeed mediated by its effects on GlyCl in *Xenopus*. The same result was obtained by misexpression of a constitutively open mutant GlyCl channel ([@b16-0040067]), or by raising endogenous glycine levels by inhibiting the glycine transporter (data not shown).

To identify the embryonic source of the signals induced by ivermectin, we investigated which cells expressed the ivermectin target GlyCl (a ligand-gated chloride channel consisting of a primary α subunit, sufficient for conductance, and a regulator β subunit) ([@b114-0040067]). In situ hybridization with an antisense probe for *GlyCl-α1* \[homologous to the mammalian glycine receptor subunit α-3 gene (*GLRA3*)\] revealed expression in early embryos ([Fig. 4A,B](#f4-0040067){ref-type="fig"}) across the neural plate region in a classic horseshoe like pattern indicative of neural crest ([@b95-0040067]). By stage 30, expression was restricted within the anterior central nervous system ([Fig. 4C](#f4-0040067){ref-type="fig"}). Sectioning revealed an enriched region in the ventral marginal zone of the neural tube ([Fig. 4E](#f4-0040067){ref-type="fig"}, red arrows, compare to sense probe control in [Fig. 4D](#f4-0040067){ref-type="fig"}). Higher resolution analysis revealed a punctate stain indicative of a sparse, broadly-distributed cell population ([Fig. 4F](#f4-0040067){ref-type="fig"}, red arrows), but no expression in the dorsal neural tube, where melanocyte precursors are located at this stage ([Fig. 4G](#f4-0040067){ref-type="fig"}). We conclude that the ivermectin target GlyCl is expressed in embryos, first in a neural-crest-associated pattern and later in a sparse punctate pattern throughout the embryo that is specifically absent from the neural crest cells themselves.

Having determined that the melanocytes themselves are not the cells expressing GlyCl (and thus are not directly depolarized by vermectin or glycine), we further tested the apparent cell-non-autonomy of this effect. One cell of embryos at the 32-cell stage was microinjected with mRNA encoding the depolarizing channel subunit KCNE1 ([@b121-0040067]) plus mRNA encoding β-galactosidase as a lineage tracer. These embryos were then treated with the MMP-blocking compound NSC-84093, which prevents melanocytes from migrating ([Fig. 1D](#f1-0040067){ref-type="fig"}). Embryos in which KCNE1 was injected in a blastomere giving rise to only posterior tissues ([Fig. 4H](#f4-0040067){ref-type="fig"}, blue arrow) still exhibited hyperpigmentation ([Fig. 4H](#f4-0040067){ref-type="fig"}, white arrowhead). Indeed, analysis of lineage label in sections ([Fig. 4I,I′](#f4-0040067){ref-type="fig"}) showed that targeting depolarizing reagents to posterior cells on one side induces the appearance of ectopic, highly dendritic, melanocytes in the head and on the opposite side. Because the migration blocker rules out cell motility as an explanation for the appearance of ectopic melanocytes in the head, we conclude that depolarized cells can exert their inductive effect at long range, not only crossing the midline to affect the contralateral side but signaling at least as far as the length of the head along the anterior-posterior axis. The same conclusion is confirmed by transplantation experiments: small domains of cells from an ivermectin-depolarized donor transplanted into an untreated embryo induce host melanocytes to arborize and migrate inappropriately ([Fig. 4J](#f4-0040067){ref-type="fig"}), whereas melanocytes from an ivermectin-depolarized donor migrate to ectopic locations in the host and acquire the same highly dendritic shape ([Fig. 4J′](#f4-0040067){ref-type="fig"}).

###### 

Proliferation rates in melanocytes
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Hyperpigmentation is mediated by *V*~mem~ change
------------------------------------------------

To determine whether the alteration of melanocyte behavior was due to GlyCl-dependent changes in transmembrane potential or some other effect of alterations in GlyCl function, we took three approaches: reversing the direction of Cl^−^ ion flow, depolarization by a GlyCl-independent method and rescue of phenotype by microinjection of a hyperpolarizing channel mRNA.

The intracellular concentration of chloride in frog embryos can be as high as 60 mM, whereas the extracellular concentration in normal 0.1× MMR medium is 10 mM ([@b58-0040067]). To cause hyperpolarization by influx of extracellular chloride into cells via ivermectin-opened GlyCl channels (supplementary material Fig. S1E), we raised the concentration of chloride in the extracellular MMR to 30 mM, 60 mM or 90 mM and examined the resulting phenotype following ivermectin exposure. Elemental analysis comparing control embryos with those reared in ivermectin plus 60 mM chloride showed a 40% increase in chloride by dry weight (0.130% and 0.185%, respectively), demonstrating that external chloride was indeed being taken up by embryonic cells when chloride channels were forced open in high-Cl^−^ medium.

Raising extracellular chloride levels to 30 mM did not inhibit hyperpigmentation, whereas 60 mM suppressed and 90 mM completely inhibited the phenotype ([Table 2](#t2-0040067){ref-type="table"}). The chloride levels tested had no observable effects on tadpole development beyond inhibiting the hyperpigmenting effects of ivermectin, and these data are precisely the outcome predicted by the Goldman-Katz equation of membrane potential: when the extracellular chloride concentration becomes equal to the intracellular, opening the GlyCl channel with ivermectin no longer depolarizes (no Cl^−^ ions will leave cells), abolishing the hyperpigmentation phenotype.

If hyperpigmentation is truly a result of membrane depolarization, then cellular voltage modulators that function independently of chloride channels should result in the same phenotype. We therefore tested the effect of disrupting the H^+^-V-ATPase hyperpolarizing pump, which we previously showed plays an important role in several voltage-regulated events in *Xenopus* development ([@b6-0040067]; [@b5-0040067]) and controls cellular *V*~mem~ through movement of H^+^, not Cl^−^, ions. Injection of low levels of mRNA encoding a well-characterized dominant-negative mutant of Ductin (the 16-kDa proteolipid subunit c of the hyperpolarizing V-ATPase pump complex) into one-cell embryos resulted in broad, long-lasting (tracked by fused YFP; data not shown) expression, which induced hyperpigmentation in 11.5% of embryos, significantly higher than background hyperpigmentation observed in controls (binomial calculation; *n*=189 for controls, *n*=192 for DN-Ductin, *P*≤0.001) ([Fig. 5A](#f5-0040067){ref-type="fig"}--C). Moreover, dn-xDuct-injected hyperpigmented embryos had 2.1-fold more melanocytes than control animals at stage 46 (Student's *t*-test, *t*=7.37, *n*=11 per treatment, *P*≤0.001; [Fig. 5D](#f5-0040067){ref-type="fig"}).

###### 

Using Cl^−^ levels to modulate voltage-dependent hyperpigmentation

![](DMM005561T2)

Finally, to confirm that misregulation of melanocyte behavior is induced by depolarization, we performed a rescue experiment. We injected Kir4.1 ([@b13-0040067]), a hyperpolarizing potassium channel ([@b70-0040067]; [@b89-0040067]), into one- or two-cell embryos before placing them into ivermectin. Ivermectin alone induced hyperpigmentation in 97.6% of embryos (*n*=73), whereas only 73.4% of embryos injected with Kir4.1 were hyperpigmented (*n*=74), a 25% reduction ([Fig. 5E](#f5-0040067){ref-type="fig"}--G). The effect was not cell-autonomous, because Kir4.1 injections into only half of the embryo (one blastomere at the two-cell stage) inhibited hyperpigmentation on both sides of the embryo ([Fig. 5H](#f5-0040067){ref-type="fig"}). Together, these data demonstrate that hyperproliferation is induced by depolarization -- not by chloride per se or by channel-independent functions of ivermectin or of GlyCl. These results also demonstrate that control of extracellular chloride, together with ivermectin, is a simple and effective technique for rational modulation of transmembrane potential in vivo.

Ivermectin-induced changes in *V*~mem~ are transduced by serotonin
------------------------------------------------------------------

How do cells sense long-term depolarization and convert this biophysical signal to changes in transcription and cell behavior? We tested three transduction mechanisms that can function downstream of depolarization: influx of Ca^2+^ through voltage-gated calcium channels (VGCC) ([@b120-0040067]; [@b123-0040067]; [@b124-0040067]), control of levels of serotonin by electrical modulation of serotonin transporter function ([@b5-0040067]; [@b54-0040067]; [@b55-0040067]; [@b108-0040067]) and electrophoretic transport of signaling molecules through gap junctions ([@b9-0040067]; [@b27-0040067]; [@b107-0040067]; [@b106-0040067]; [@b193-0040067]). Our strategy was to apply inhibitors of each of these pathways together with ivermectin, to determine which mechanism is required for depolarization to be effectively transduced into changes of melanocyte behavior.

![**Hyperpigmentation is due to depolarization.** Microinjection of a dominant-negative form of ductin (dn-xDuct) at the one-cell stage inhibits the hyperpolarizing H^+^-V-ATPase and results in hyperpigmentation (A,B). Injections result in hyperpigmented tadpoles in 11.5% of embryos (C), significantly higher than background levels observed in control embryos. Hyperpigmented embryos arising from dn-xDuct injections were photographed and the number of melanocytes in the eye field counted; there was a 2.1-fold increase in number of melanocytes compared with age-matched controls (D). By contrast, overexpression of the hyperpolarizing potassium channel Kir4.1 (E,F) inhibits ivermectin-induced hyperpigmentation in 25% of injected embryos (G). Kir4.1-mediated inhibition was non-cell-autonomous, because one of two cell injections, resulting in hyperpolarizing channel activity on just one side of the embryo, inhibited hyperpigmentation on both the left and right side of the embryos (H).](DMM005561F5){#f5-0040067}

Treatment with potent VGCC blockers (0.1 mM cadmium chloride, 0.1 mM verapamil) or with the gap junction blocker lindane (1.7 mM) did not result in any reduction in ivermectin-induced hyperpigmentation ([Table 3](#t3-0040067){ref-type="table"}). However, exposure to a specific inhibitor of the serotonin transporter (10 μM fluoxetine) blocked ivermectin-induced hyperpigmentation in all of the treated embryos, without any apparent effects on overall patterning or embryo health.

###### 

Rescue of hyperpigmentation phenotype reveals serotonergic involvement

![](DMM005561T3)

To determine whether ivermectin-induced depolarization and the function of the serotonin transporter SERT were taking place in the same cells, we performed immunohistochemistry for both receptors on sections of stage 32 *Xenopus* embryos. SERT protein expression significantly overlapped with that of glycine receptors in cells of the ventral neural tube, suggesting that cells sensitive to ivermectin also respond to fluoxetine ([Fig. 6A--C](#f6-0040067){ref-type="fig"}).

Fluoxetine increases the availability of extracellular serotonin by blocking its internalization. To ensure that the hyperpigmentation was indeed due to serotonergic signaling and not some other role of SERT or an off-target effect of fluoxetine, we treated embryos with excess extracellular serotonin. This resulted in a consistent and powerful hyperpigmentation ([Fig. 6D,E](#f6-0040067){ref-type="fig"}). Taken together, the data strongly suggest that function of the serotonin transporter SERT is required for the transduction of *V*~mem~ changes into cell behavior changes observed during hyperpigmentation.

Human epidermal melanocytes respond to changes in membrane potential
--------------------------------------------------------------------

Although simple in vitro culture cannot demonstrate the non-cell-autonomous effects observed in the embryo, we investigated whether human epidermal melanocytes showed any phenotypes as a result of membrane depolarization. Ivermectin could not be used to depolarize the membrane because the required culture medium of this cell line has a very high chloride content. Instead, we raised extracellular K^+^ levels by addition of potassium gluconate, which also depolarizes cells (reduces the ability of K^+^ ions to exit cells through potassium channels). This also has the advantage of testing a voltage role independent of chloride per se.

No measurable differences in cell proliferation were noted between melanocytes cultured in standard vs high-K^+^ media (data not shown). However, cells grown in high-K^+^ medium demonstrated a striking shape change similar to *Xenopus* melanocytes exposed to ivermectin. Following 2 days of culture in 50 mM potassium-gluconate-supplemented medium, human melanocytes developed a highly arborized morphology, with many cells showing five or more projections (compare [Fig. 7A with B](#f7-0040067){ref-type="fig"}). Quantification showed that culturing cells in high-K^+^ medium had a significant effect on the number of projections on melanocytes (2-way ANOVA, *F*~3~=18.29, *P*≤0.001). To verify that melanocytes grown in high-K^+^ medium were in fact depolarized, we made use of ratiometric *V*~mem~ imaging using CC2-DMPE and DiBAC~4~(3) dyes to visualize the membrane potential ([Fig. 7D,E](#f7-0040067){ref-type="fig"}). Comparison of treatments showed depolarization of treated cells compared with controls ([Fig. 7F](#f7-0040067){ref-type="fig"}, *t*~22~=3.77, *P*=0.001). We conclude that some of the novel mechanisms that we observed in *Xenopus* larvae are not restricted to embryogenesis and might be relevant to human adult melanocytes.

![**Serotonergic controls of melanocyte behavior and their relationship to GlyCl-expressing cells.** (A) Sections of a stage 32 embryo processed by immunohistochemistry with an anti-GlyCl antibody and visualized with a fluorescent secondary antibody (Alexa Fluor 647). (B) The same section processed by immunohistochemistry with an anti-SERT antibody and visualized with Alexa Fluor 546. (C) Merge of A and B showing colocalization of GlyCl and SERT. Yellow arrowheads indicate areas of overlapping expression (cells containing both GlyCl and SERT). Unlike controls (D), embryos treated with external serotonin acquire the hyperpigmentation phenotype (E), consistent with SERT mediating the effect of depolarized GlyCl-expressing cells on melanocytes. White arrow indicates a region normally devoid of melanocytes; red arrowhead indicates ectopic melanocytes.](DMM005561F6){#f6-0040067}

![**Human melanocytes exhibit arborization when the membrane is depolarized.** In normal culture medium, human melanocytes typically develop two or three projections (A). When grown in media supplemented with 50 mM potassium gluconate, cells develop a more arborized morphology, with many cells having four or five, or more, projections (B). Comparisons between treatments (C) demonstrate a significant effect of potassium gluconate on arborization of melanocytes. Error bars indicate one standard deviation. Image analysis (using the membrane voltage sensor pair CC2-DMPE and DiBAC~4~) comparing controls (D) and cells cultured in high-potassium medium (E) revealed the predicted depolarization (lower intensity of pixels) in response to the high-potassium media (F). Red arrowheads indicate depolarized cell membranes; white arrows indicate lack of depolarization in membrane.](DMM005561F7){#f7-0040067}

DISCUSSION
==========

Control of melanocyte behavior by *V*~mem~
------------------------------------------

Prior work has examined the behavior of melanocytes within exogenous electrical fields ([@b60-0040067]; [@b163-0040067]). However, the role of transmembrane potential in the regulation of neural crest derivatives or the molecular basis for any bioelectrical controls of melanocyte behavior has not previously been examined. Our fundamental finding is that modulation of membrane potential by changing the direction of chloride flux in GlyCl-positive cells robustly and non-cell-autonomously confers a hyperproliferative, inappropriately colonizing phenotype upon melanocytes in *Xenopus* larvae ([Fig. 1A--C](#f1-0040067){ref-type="fig"}). Changes in *V*~mem~ were induced by forcing chloride channels open with the specific agonist ivermectin, followed by control of Cl^−^ concentration in the medium, a convenient technique with which transmembrane potential can be increased or decreased as desired. The resulting hyperpigmentation in depolarized tadpoles is a result of inappropriate MMP-dependent migration, cell shape change and greater melanocyte number ([Fig. 1D](#f1-0040067){ref-type="fig"}; [Figs 2](#f2-0040067){ref-type="fig"}, [3](#f3-0040067){ref-type="fig"}); depolarization induced no increase in the amount of melanin pigment per melanocyte. The altered behavior of melanocytes includes arborization, the ability to penetrate and colonize internal organs and neural structures, and the formation of long processes that are highly uncharacteristic of normal melanocytes ([Fig. 2](#f2-0040067){ref-type="fig"}). Future work tracing the behavior of small numbers of labeled, depolarized instructor cells transplanted into a wild-type host will be necessary to determine whether the metastasis of ivermectin-treated melanocytes to inappropriate locations is due to altered control of pathfinding at the single-cell level or to a community ('population pressure') effect ([@b14-0040067]) among high numbers of melanocytes that repel one another ([@b115-0040067]).

There are two phases to the effect. When treatment with depolarizing agent occurs during neurulation, significant increases in pre-melanocyte number occur (a 1.5-fold increase in melanocyte number is observed in periocular skin and a 2.8-fold increase in mitotic melanocytes is observed when all tissues in section are analyzed via H3B-*P* staining). The effect seems to be mediated by increased proliferation of melanocytes, not recruitment of additional cells into the melanocyte lineage ([Fig. 3D--G](#f3-0040067){ref-type="fig"}). By contrast, treatment beginning later at organogenesis stages does not induce significant increases in proliferation ([Fig. 3C](#f3-0040067){ref-type="fig"}), demonstrating that mitosis and shape and/or migration change in melanocytes are separable processes. Although both changes of melanocyte behavior result from depolarization of transmembrane potential in GlyCl-positive cells, the distinct natures of the two phenotypes is underlined by the fact that, although excess melanocytes do not disappear following withdrawal of ivermectin, shape rapidly returns to normal following washout ([Fig. 2G,H](#f2-0040067){ref-type="fig"}).

The early phase might be cell-autonomous, because the chloride channel target is expressed in neural crest cells (precursors of melanocytes) during the time of exposure ([Fig. 4A,B](#f4-0040067){ref-type="fig"}). By contrast, the effects of later depolarization are likely to be non-cell-autonomous, because (1) at somite stages the receptor is expressed in cells that are at a considerable distance from the melanocytes whose behavior is altered by induced chloride efflux ([Fig. 4F,G](#f4-0040067){ref-type="fig"}), (2) hyperpolarization of cells via Kir4.1 on half of the embryo inhibits hyperpigmentation on both sides ([Fig. 5H](#f5-0040067){ref-type="fig"}) and (3) depolarization of posterior cells on one side of the midline results in the appearance of ectopic melanocytes in the head of the embryo on the opposite side even when migration is inhibited ([Fig. 4H--I′](#f4-0040067){ref-type="fig"}). Such long-range effects of biophysical changes are a fascinating aspect for future investigation because they suggest opportunities for biomedicine as well as potential sources of unexpected problems in patients taking drugs targeting ion channels.

A connection between ion transport proteins and pigment cell behavior has been observed in zebrafish, specifically between Kir7.1 and melanosomes ([@b78-0040067]), as well as between connexin 41.8 and pigment cells (in a diffusion-reaction patterning system) ([@b12-0040067]; [@b183-0040067]). However, our data specifically connect the control of *V*~mem~ in one cell population (GlyCl-expressing instructor cells) with migration, morphology and proliferation in another (pigment cells). Indeed, we show that the phenomenon of membrane-voltage-based signaling is even more directly recapitulated in human pigment cells ([Fig. 8](#f8-0040067){ref-type="fig"}), suggesting that the previously observed stimulatory effects of bee venom on human melanocytes ([@b82-0040067]) is due to the ion-channel-targeting properties of its apamin protein component ([@b153-0040067]). More broadly, the voltage control mechanism might be a plausible candidate for biomedical intervention in the pigmentation disorder vitiligo ([@b112-0040067]; [@b186-0040067]), in melanoma ([@b190-0040067]; [@b191-0040067]) and, more broadly, in neurocristopathies (developmental birth defects involving neural crest stem cell derivatives) ([@b24-0040067]; [@b41-0040067]; [@b76-0040067]).

![**A model of melanocyte control by transmembrane potential of cells in the neural crest's environment.** (A) In unperturbed embryos, several classes of ion transporters keep the plasma membrane polarized. This transmembrane potential powers the reuptake of extracellular serotonin through its transporter SERT, resulting in normal melanocyte behavior. (B) By contrast, when the instructor cell population (demarcated by GlyCl expression) is depolarized by targeted modulation of H^+^, Cl^−^ or K^+^ channel/pump function, the SERT runs backwards and not only fails to clear the extracellular space of serotonin, but actually exports additional serotonin. The higher serotonin level in the milieu of the neoblasts induces neoplastic-like behavior in melanocytes, as occurs in human cancers. This pathway can be manipulated at a number of points. Consistent with this model, our data show that, although direct serotonin exposure or depolarization of GlyCl-expressing cells can induce hyperpigmentation, the depolarization phenotype can be prevented by overexpression of hyperpolarizing channels or inhibition of SERT. Central features of this model are the regulation of cell behavior by transmembrane potential, regardless of which specific gene product achieves it, and non-cell-autonomous effects of a cell subpopulation specifically instructing, at considerable distance, one derivative of neural crest to undergo the stem-cell-to-neoplastic-cell-like phenotype.](DMM005561F8){#f8-0040067}

GlyCl as a marker of a unique cell population in embryos
--------------------------------------------------------

One of the advantages of ivermectin-based depolarization is that the target cells can easily be identified. Ivermectin is a highly specific agonist for GlyCl ([@b154-0040067]), and our phenotype results from the effects on GlyCl rather than off-target side effects of this compound, because its native ligand, glycine, can induce the same effect (supplementary material Fig. S2). Whereas GlyCl is normally expressed in some neurons (spinal cord, retina) and sperm ([@b114-0040067]), we detected a dynamic and highly interesting distribution during frog embryogenesis. It is first expressed in the dorsal neural tube during stage 15 ([Fig. 4A,B](#f4-0040067){ref-type="fig"}) and is later enriched in the ventral neural tube ([Fig. 4C--F](#f4-0040067){ref-type="fig"}), at the same location from which N-tubulin-positive motor neurons arise ([@b151-0040067]). At post-neurula stages (e.g. stage 30), it is also present in a unique pattern throughout the interior of the embryo, in a sparse population of small cells resembling macrophages in size ([@b172-0040067]). It is specifically not expressed in melanocytes ([Fig. 4G](#f4-0040067){ref-type="fig"}). Importantly, nearly all ivermectin-treated embryos acquire the hyperpigmented phenotype; by contrast, depolarizing arbitrary (even large) groups of cells by forcing KCNE1 overexpression only affects ∼20% of the embryos ([@b121-0040067]), underscoring the significance of the native GlyCl-expressing cells.

This speckled arrangement of the ivermectin-sensitive cells is especially useful for research because it facilitates exploration of a highly mosaic depolarization effect, a powerful technique resembling the mosaic analysis that has been capitalized on by the *Drosophila* community and is difficult to achieve with ubiquitous *V*~mem~-modulating methods such as ionophores. Inducing chloride efflux in a small population of cells induced a highly specific phenotype in which the behavior of melanocytes was radically affected despite completely normal development of the anterior-posterior axis, major organs and other neural crest derivatives such as branchial arches. It is remarkable that depolarization of a rare cell population is able to induce a very specific but almost 100%-penetrant phenotype in just one cell type during embryogenesis.

Transduction, voltage sensing and melanocyte regulation by serotonin
--------------------------------------------------------------------

Chloride influx (induced by activation of GlyCl and demonstrated directly using ion chromatography analysis) induces an increase in melanocyte number. Although chloride channels have been linked to mitotic control ([@b169-0040067]; [@b177-0040067]), the pathway resulting in hyperpigmentation is not restricted to chloride-specific signaling but is rather controlled by *V*~mem~. This is indicated by the fact that other methods for depolarizing cells, such as inhibition of hyperpolarizing H^+^ pumps ([Fig. 5A--D](#f5-0040067){ref-type="fig"}) or potassium channels ([Fig. 8](#f8-0040067){ref-type="fig"}) ([@b121-0040067]), result in the same phenotype. Moreover, the phenotype can be rescued by misexpression of a hyperpolarizing channel ([Fig. 5F--H](#f5-0040067){ref-type="fig"}). Thus, the modulation of melanocyte behavior is not a consequence of some cryptic role of ivermectin, nor of the Cl^−^ ion, but of *V*~mem~. However, chloride channels are a tractable mechanism (endogenously, and experimentally) for controlling *V*~mem~ in distinct cell groups.

It is known that prolonged depolarization activates proliferation of some cell types ([@b20-0040067]; [@b36-0040067]; [@b130-0040067]), as we observed in human melanocytes, although the mechanism is largely unknown. Interestingly, sustained ivermectin treatment in *Xenopus* does not result in generalized runaway hyperproliferation but affects a specific cell type; it remains to be understood why the GlyCl-expressing cells instruct only melanocytes and not other cell types. Depolarization induced approximately one extra cell cycle ([Fig. 5D](#f5-0040067){ref-type="fig"} and [Fig. 3C](#f3-0040067){ref-type="fig"}), which is a very strong effect because it occurred within about a day of exposure, whereas melanocyte doubling normally takes 8--10 days in *Xenopus* ([@b56-0040067]). Thus, depolarization might not be a generalized and direct inducer of mitosis but rather a signal that can stimulate specific instructor cells to trigger a defined and limited change in cell number of specific other cell populations.

Our data are also consistent with previous observations showing abnormal neural crest migration in embryos exposed to electric fields ([@b25-0040067]). Although direct application of fields to complex tissues is a somewhat blunter tool than molecular changes of ion fluxes in defined cells, applied electric fields can depolarize cells, and such a treatment also results in hyperpigmentation (data not shown). Because melanocytes do not migrate directionally in physiological direct current (DC) electric fields ([@b60-0040067]; [@b77-0040067]), these effects are probably mediated by transmembrane potential and not long-range electric fields induced by ion channel activity.

How are changes in transmembrane voltage transduced into alterations of cell behavior? Activation of voltage-gated calcium channels is a common mechanism ([@b127-0040067]), although our data ([Table 3](#t3-0040067){ref-type="table"}) offer no support for the role of Ca^2+^ in the depolarization effect. Instead, a serotonin-dependent mechanism is implicated downstream of chloride-dependent *V*~mem~ changes. Blockade of the serotonin transporter SERT suppresses the hyperpigmentation phenotype ([Table 3](#t3-0040067){ref-type="table"}). Moreover, the well-established role of SERT as part of the reuptake mechanism that lowers extracellular levels of serotonin suggests that high external levels of serotonin ought to mimic the hyperpigmentation effect. This was indeed observed ([Fig. 6D,E](#f6-0040067){ref-type="fig"}). The direction of serotonin transport by SERT is controlled by transmembrane potential ([@b108-0040067]), and serotonin is a known mitogen ([@b47-0040067]; [@b125-0040067]). Consistently, melanocytes are known to express serotonin receptors ([@b156-0040067]), and serotonergic signaling has been reported to induce a doubling of melanocytes in human skin ([@b79-0040067]), precisely as we observed.

Together, the data suggest a model in which modulation of serotonin levels (by SERT-dependent clearance of serotonin from intercellular spaces) is a mechanism by which depolarization can activate proliferation. This is particularly plausible for melanocytes because serotonergic signaling has been linked to secretion of α-melanocyte-stimulating hormone ([@b31-0040067]; [@b157-0040067]); thus, we propose the following model. In unperturbed embryos ([Fig. 8A](#f8-0040067){ref-type="fig"}), the 'instructor' cells are polarized by the activity of several ion transporters. The resulting transmembrane gradient powers the function of coexpressed SERT, allowing this reuptake to reduce the level of extracellular serotonin (as occurs in synapses). In the absence of elevated extracellular serotonin levels, melanocytes maintain their normal levels of proliferation, obey normal migration cues and exhibit a rounded shape. By contrast ([Fig. 8B](#f8-0040067){ref-type="fig"}), if the membrane is depolarized (by targeting H^+^, K^+^ or Cl^−^ transport; [Figs 1](#f1-0040067){ref-type="fig"}, [5](#f5-0040067){ref-type="fig"}), SERT cannot clear the surrounding space. Indeed, it runs backwards ([@b7-0040067]; [@b71-0040067]) to enrich the milieu with excess serotonin content ([Fig. 6D,E](#f6-0040067){ref-type="fig"}). This is a non-cell-autonomous signal and is consistent with a number of serotonin receptors being expressed in melanocytes ([@b157-0040067]) as well as classical data on serotonergic control of melanocytes in frog skin ([@b179-0040067]).

As in left-right patterning ([@b55-0040067]; [@b107-0040067]), serotonin acts in this system as a small-molecule messenger mediating cell-cell instructive signaling downstream of changes in transmembrane potential. Indeed, animals injected with serotonin developed neural crest tumors ([@b128-0040067]), suggesting that serotonergic signaling is an important component of tumorigenesis. Future work will identify the receptor mechanisms by which melanocytes respond to serotonin or potential downstream factors to acquire a neoplastic-like phenotype.

Voltage changes in development and cancer
-----------------------------------------

Most cancer cell types exhibit a characteristic depolarization of membrane potential compared with healthy tissue ([@b23-0040067]; [@b94-0040067]). However, our in vivo experiments revealed a non-cell-autonomous instructive function for GlyCl-expressing cells that would not be apparent from in vitro experiments: depolarization can induce a neoplastic-like phenotype in cells that themselves are not (yet) depolarized ([Fig. 4](#f4-0040067){ref-type="fig"}). Strikingly, human melanocytes exhibit an even more direct, cell-autonomous component of the depolarization phenotype ([Fig. 7](#f7-0040067){ref-type="fig"}). One of the interesting features of the melanocyte phenotype is the appearance of very long projections ([Fig. 2J](#f2-0040067){ref-type="fig"}); it is not yet known whether this is associated with nerves, for example using axons as guidance cues. This might also be related to the striking finding that highly aggressive melanoma cells can be coaxed to produce vascular networks in three-dimensional culture ([@b117-0040067]).

Indeed, there is a fascinating and still poorly understood relationship between cancer and developmental processes ([@b101-0040067]; [@b146-0040067]; [@b182-0040067]). On transplantation of human metastatic melanoma cells into premigratory neural crest of chick embryos, the melanoma cells became distributed along neural crest migratory pathways, lost tumorigenic potential and acquired normal neural crest features ([@b48-0040067]; [@b90-0040067]). Our data illustrate the flip side of normalizing metastatic tumor cells with embryonic microenvironments ([@b66-0040067]; [@b84-0040067]; [@b90-0040067]): depolarization of somatic cells is a physiological (epigenetic) component of the embryonic microenvironment that, like acidification ([@b30-0040067]), can contribute to a transformation of the behavior of embryonic stem cell derivatives into cancer-like cells.

Neural crest stem cell derivatives are known to contribute to several tumor types, including melanoma, neuroblastoma and pheochromocytoma ([@b53-0040067]). The depolarization phenotype is neoplastic-like -- although there is no primary tumor (as in small-cell lung carcinoma, for example), the effect fulfils three classic criteria for cancer: cell shape change, invasiveness and overproliferation. Moreover, the drug NSC-84093 -- an MMP inhibitor ([@b173-0040067]) -- prevents colonization of ectopic sites in the embryo, as it does in adult animal cancer models ([@b65-0040067]). Thus, the hyperpigmentation phenotype seems to be similar in mechanistic ways to the metastatic phase of cancer.

What is the relevance of our data for cancer, and melanoma specifically? Uncontrolled growth and dispersal of melanocytes can lead to melanoma ([@b85-0040067]; [@b162-0040067]; [@b185-0040067]). Melanoma cell migration ([@b110-0040067]), as well as migration of other cell types ([@b83-0040067]), is known to be dependent on potassium channels ([@b39-0040067]; [@b88-0040067]; [@b111-0040067]; [@b139-0040067]; [@b152-0040067]; [@b160-0040067]; [@b189-0040067]) and a number of ion channels have been characterized as markers and likely causes of neoplasm ([@b10-0040067]; [@b17-0040067]; [@b42-0040067]; [@b52-0040067]; [@b51-0040067]; [@b97-0040067]; [@b122-0040067]; [@b132-0040067]; [@b135-0040067]; [@b140-0040067]; [@b188-0040067]). Indeed, ion channels are increasingly becoming high-priority targets for anti-neoplastic therapy ([@b11-0040067]; [@b73-0040067]; [@b94-0040067]), and monitoring of electrical properties is being used as a diagnostic tool ([@b1-0040067]; [@b46-0040067]; [@b61-0040067]; [@b133-0040067]). Our data suggest that control of *V*~mem~ is a key component of this set of pathways, and as such is a promising target of treatments for melanoma as well as other types of neoplasm. In particular, *V*~mem~ might be an important and novel regulator of the stem cell-cancer cell transition ([@b86-0040067]; [@b109-0040067]; [@b168-0040067]; [@b170-0040067]; [@b187-0040067]). We are currently pursuing strategies for early, non-invasive cancer detection using voltage-sensitive fluorescent reporter dyes and techniques to normalize cancer by repolarizing neoplastic cells and instructor cell populations.

GlyCl as a target for rational modulation of bioelectric signals in regenerative medicine
-----------------------------------------------------------------------------------------

It is important to note that the effect described by the above data is not simply a function of the GlyCl protein, nor is it inherently tied to chloride flux ([Fig. 5](#f5-0040067){ref-type="fig"}). Although GlyCl is a convenient target for voltage modulation, this pathway is not limited to any one gene product but rather is driven by changes in a biophysical parameter, *V*~mem~, that is determined by the activity of multiple transporters. Our data shed light on a control mechanism operating during normal embryogenesis that can regulate neural crest stem cell dynamics, as well as identifying a new environmental parameter that might be involved in neoplastic processes.

Indeed, the data suggest a new strategy for rational control of cell behavior in regenerative medicine. Our method was to identify an ion channel that is present in a specific cell population, and modulate *V*~mem~ by opening that channel while designing the external medium in such a way as to direct ion flux towards the desired *V*~mem~ change. We used ivermectin-sensitive GlyCl, which works very well, plus ivermectin is already approved for human use as an antiparasitic ([@b69-0040067]). However, this strategy can be used with any channel (especially potassium channels) for which openers and closers are available, and the above data show that it is possible to use the Goldman-Katz equation to quantitatively design a strategy to rationally modulate transmembrane potential. Previously, we have shown that control of transmembrane potential is a powerful tool for understanding and inducing complex regenerative responses ([@b6-0040067]; [@b103-0040067]; [@b104-0040067]; [@b165-0040067]). This approach can be used to control *V*~mem~ changes in well-defined cell groups in vivo with temporal modulation.

Moreover, the unique and unusual expression pattern reveals GlyCl as a marker for a potentially highly important cell type: a kind of 'instructor cell' that can signal other populations (e.g. neural crest) and drastically change their behavior at considerable distance ([Fig. 4H--I′](#f4-0040067){ref-type="fig"}, [Fig. 5G,H](#f5-0040067){ref-type="fig"}). Analysis of expression of other ion channels and pumps might reveal yet other subsets of otherwise homogenous-seeming cell groups, which, like the GlyCl-expressing cells, could be tractable targets for modulation in regenerative medicine. For example, melanocytes can build vessels through vasculogenic mimicry ([@b67-0040067]; [@b117-0040067]), and voltage control should be investigated as a technique for controlling shape in bioengineering contexts ([@b2-0040067]).

Future work will surely reveal additional fascinating roles for specific ion flows in morphogenesis. Taken together, our data reveal *V*~mem~ as a tractable mechanism of morphogenetic regulation, with relevance to normal embryonic development and neoplasm, and suggest a pharmacological strategy for *V*~mem~ modulation that might be of use in several branches of biomedicine.

METHODS
=======

Animal husbandry
----------------

*Xenopus* embryos were maintained according to standard protocols ([@b155-0040067]) in 0.1× MMR, pH 7.8, plus 0.1% gentamicin. *Xenopus* embryos were staged according to Nieuwkoop and Faber ([@b126-0040067]).

Expression analysis
-------------------

In situ hybridization was performed as previously described ([@b64-0040067]). *Xenopus* embryos were collected and fixed in MEMFA ([@b155-0040067]). Prior to in situ hybridization, embryos were washed in phosphate buffered saline (PBS) + 0.1% Tween-20 (PBST) and then transferred to methanol through a 25%/50%/75% series. Probes for in situ hybridization were generated in vitro from linearized templates using a DIG labeling mix from Roche. Chromogenic reaction times optimized signal:background ratio. Analyses represent consistent patterns from 50--60 embryos for each marker. Probes used for in situ hybridization include: sense and antisense GlyCl-α (NCBI accession \#CX801861), and GlyCl-β (NCBI accession \#BC121237). Anti-GlyCl (Chemicon 5052 used at 1:200 dilution) and -SERT (Chemicon MAB5618 used at 1:100 dilution) antibodies were used for immunohistochemistry using previously described protocols ([@b102-0040067]).

Microinjection
--------------

Capped, synthetic mRNAs were dissolved in water and injected into embryos in 3% Ficoll using standard methods ([@b155-0040067]). After 3 hours, embryos were washed and cultured in 0.1× MMR until the desired stages were reached. Constructs used for misexpression included: dominant-negative E140K mutant of ductin (the 16 kDa subunit of the V-ATPase) ([@b5-0040067]; [@b49-0040067]), the KCNE1 accessory subunit ([@b121-0040067]), the GlyCl wild-type channel ([@b40-0040067]) and the potassium channel Kir4.1 ([@b13-0040067]).

Drug exposure
-------------

Stocks of ivermectin (Sigma) were kept at 10 mM concentration in dimethyl sulfoxide (DMSO). Embryos were exposed in 0.1× MMR for the stages indicated to: ivermectin, 1 μM; cadmium chloride, 0.1 mM; verapamil, 10 μM; fluoxetine, 10 μM; lindane, 1.7 mM; NSC-84093, 2 μM; and glycine, 0.13 mM.

Elemental analysis
------------------

For elemental analysis, cohorts of stage 13 embryos were either untreated or exposed to a combination of 10 μM ivermectin + MMR containing 60 mM Cl^−^. At stage 30, 2 ml of packed embryo were collected from each cohort and washed three times in 0.1× MMR. Excess media was removed from the samples and the embryos were stored at −80°C before shipping to Galbraith Laboratories (Knoxville, TN) for dry analysis of chlorine concentration. Samples were prepared by Parr oxygen bomb combustion and analyzed by ion chromatography. Results are reported as percent chloride in total sample based on dry mass.

Measurement of melanocyte numbers
---------------------------------

Melanocytes were counted by cellAnalyst software (AssaySoft) on digital photographs of anesthetized larvae. Adobe Illustrator was used to define the dorsal region between the eyes used for counting. Tail regions were defined using digital photographs: all melanocytes within a 400×400 pixel box, extending anteriorly from the tip of the tail, were counted.

Immunohistochemistry
--------------------

Spatial detection of apoptosis and proliferation was performed by immunohistochemistry in section. We chose caspase-3 staining as a more specific detector of apoptosis ([@b32-0040067]; [@b116-0040067]; [@b192-0040067]) than classical methods such as TUNEL, which gives considerable levels of false positive signal ([@b161-0040067]). Briefly, larvae were fixed overnight in MEMFA ([@b155-0040067]), embedded in agarose and sectioned at 100 μm using a Leica vibratome. The sections were permeabilized in PBS + 0.1% Triton X-100 for 30 minutes, blocked with 10% goat serum PBST for 1 hour, and incubated at 4°C overnight with primary antibody (anti-activated-caspase-3; Abcam \#AB13847) for apoptosis ([@b50-0040067]), or anti-H3B-*P*, Upstate \#05-598) for proliferation, diluted 1:1000 in PBST + 10% goat serum. They were then washed six times with PBST (1 hour each at room temperature) and incubated with Alexa-Fluor-555-conjugated secondary antibody at 1:1000 in PBST + 10% goat serum overnight at 4°C. Sections were photographed using the appropriate filter set on a Nikon SMZ-1500 scope with epifluorescence after six 1-hour washes in PBST.

Direct measurement of melanin content
-------------------------------------

Melanin content of embryos was measured as described previously ([@b138-0040067]) with slight modification. In brief, five stage-45 embryos were hydrolyzed in 0.2 ml 1 M NaOH for 96 hours at 37°C, and 0.15 ml was diluted to 1 ml with H~2~O, and used for spectrophotometric determination of the absorption at 414 nm.

Human melanocyte culture
------------------------

Human melanocytes were obtained commercially and cultured in DermaLife M Melanocyte culture medium (cells and media provided by Lifeline Cell Technology, Walkersville, MD). Cells were maintained in standard 25-cm^2^ culture flasks; the 10 ml of media was replaced every other day. On reaching confluence, melanocytes were passaged using a standard trypsinization protocol, and new colonies were seeded at approximately 5000 cells/cm^2^. For high-potassium-media experiments, DermaLife M media was supplemented with 40 mM potassium gluconate, a level determined during a preliminary potassium dose-response screen to be non-inhibitory to growth while inducing morphological changes.

For cell shape analysis, cells were imaged on a Nikon AZ100M stereomicroscope and the numbers of filopodia on all cells within the field of vision were counted. Cell culture in high-potassium media was repeated three times and the results averaged for statistical analysis.

Imaging *V*~mem~ using CC2-DMPE and DiBAC~4~(3)
-----------------------------------------------

CC2-DMPE \[N-(6-chloro-7-hydroxycoumarin-3-carbonyl)-dimyristoylphosphatidyl ethanolamine\], a cationic coumarin phospholipid, and the anionic oxonol DiBAC~4~(3) \[bis-(1,3-dibutylbarbituric acid) trimethine oxonol\] were purchased from Invitrogen. Using two dyes with opposite emission profiles simultaneously provides an internal control and allows results to be corrected for artifact by ratiometric normalization. Stock CC2-DMPE solution was prepared according to manufacturer's directions: a 5 mM stock (in DMSO) was prepared, aliquoted and stored at −20°C until immediately before use. DiBAC~4~(3) stock (1.9 mM in DMSO) was prepared and stored at room temperature. CC2-DMPE stock was dissolved 1:1000 directly into culture medium. DiBAC~4~(3) stock was dissolved 1:2 in DMSO, then spun at RCF 20,800 for 10 minutes to remove undissolved particles of dye. Supernatant was then diluted 1:4000 in culture media. 1 ml of CC2-DMPE was added to cells grown in 35-mm FluoroDish Sterile Culture Dishes. Cells were incubated for 30 minutes, then washed twice with plain culture media. 1--2 ml of DiBAC~4~(3) were then added to the dish. Cells were incubated at least 30 minutes before imaging began; cells were imaged while in the DiBAC~4~(3) bath. A round coverslip was dropped into the dish, and any medium outside the well was removed. The dish was then turned over and the cells imaged through the glass bottom of the dish.

An Olympus BX-61 equipped with a Hamamatsu ORCA AG CCD camera, and controlled by IPLabs, was used for imaging. CC2-DMPE is imaged with the following filters: EX 405/20; BS 425; EM 460/50 (Chroma filter set 31036). DiBAC~4~(3) is imaged with: EX 470/20; BS 485; EM 517/23 (Chroma filter set 41001). After dark-field (to remove camera noise) and flat-field (to correct for uneven illumination) corrections, image arithmetic was used to take the ratio of CC2-DMPE intensity over DiBAC~4~(3) intensity. The result is an artifact-corrected picture of *V*~mem~; the brighter the pixel, the more polarized the region it represents. Images were pseudocolored to make the contrast between different regions more easily visible. No calibration was performed; nonetheless, pixel intensity within and among images can be compared for relative quantification. Except for resizing during figure preparation, no other changes were made to the images; thus, pixel intensity or color are reliable reporters of *V*~mem~. Original images are available on request.

Statistics
----------

All statistical analyses were performed using Prism v.5 (GraphPad Software, La Jolla, CA). Student's *t*-tests were used for comparisons of melanocyte number, incidence of hyperpigmented tadpoles and cell intensity for microscopy experiments. Filopodial numbers in human melanocytes were compared using a two-way ANOVA. Data conformed to parametric requirements; no corrections were needed for normality or variance.
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